Sanofi

US state Hawaii announced on Friday it had accepted a $700 million settlement in its case against US pharmaceutical company Bristol-Myers Squibb (BMS) and subsidiaries of French drug group Sanofi over the blood thinner Plavix. The...

GSK plc announced the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) authorized Sanofi’s SARS-CoV-2 spike protein (B.1.351 strain) vaccine for the prevention of COVID-19 disease in adults aged 18 and above in Great Britain,...

French pharmaceutical firm Sanofi said Tuesday it was abandoning work on an mRNA vaccine against Covid-19 despite positive test findings as it trails behind rivals on delivering a coronavirus shot. The business said it will focus...

French pharmaceutical giant Sanofi and Britain’s GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world’s arsenal against the pandemic. The companies reported...

Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine. Together, the two organizations and their scientists will work to advance the understanding of immunology and inflammation through open scientific exchange. Additionally,...

Sanofi has signed on December 10th a renewed partnership agreement with the World Health Organization (WHO), consolidating a 20-year collaboration to fight some of the most Neglected Tropical Diseases (NTDs) and supporting the WHO in its...

Pharma giants Sanofi and GlaxoSmithKline will join forces to work on a coronavirus vaccine they hope will enter clinical trials this year, potentially making it available in the second half of 2021, the companies said Tuesday....

Sanofi has committed to donating 100 million doses of hydroxychloroquine to 50 countries around the world, and has begun to progressively deliver the medicine to authorities that have requested it. HYDROXYCHLOROQUINE DONATION In this global health...

French pharmaceutical giant Sanofi said Friday it would offer 100 million doses of hydroxychloroquine, a treatment for rheumatoid arthritis and lupus, to governments worldwide if studies show it can safely to be used to treat COVID-19...

At Sanofi‘s meeting on June 6th of 2019, Sanofi’s Board of Directors unanimously appointed Paul Hudson as Chief Executive Officer of the Group, to succeed Olivier Brandicourt who has decided to retire. The Board of Directors would...